Microbot Medical Inc. (MBOT)
NASDAQ: MBOT
· Real-Time Price · USD
3.07
-0.06 (-1.92%)
At close: Aug 15, 2025, 2:44 PM
Microbot Medical Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -12.71M | -11.67M | -11.44M | -11.21M | -10.44M | -10.26M | -10.74M | -10.58M | -11.61M | -12.83M | -13.17M | -14.03M | -13.12M | -12.11M | -11.31M | -10.09M | -10.01M | -9.35M |
Depreciation & Amortization | 76K | 78K | 91K | 100K | 97K | 109K | 106K | 104K | 109K | 106K | 102K | 97K | 88K | 79K | 76K | 63K | 66K | 69K |
Stock-Based Compensation | 1.06M | 1.15M | 1.35M | 1.36M | 1.42M | 1.44M | 1.4M | 1.53M | 1.65M | 1.74M | 1.75M | 1.69M | 1.54M | 1.41M | 1.39M | 1.49M | 1.74M | 2M |
Other Working Capital | 1M | 928K | 707K | -507K | -154K | -16K | -11K | -110K | -587K | -719K | -228K | 266K | 294K | 262K | 497K | 495K | 639K | 667K |
Other Non-Cash Items | -8K | -451K | -216K | 605K | 1.22M | 979K | 717K | -112K | -43K | -35K | -7K | 1K | 2K | 1K | -34K | -123K | -123K | 3.25M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 1.69M | 1.61M | 1.39M | 178K | -154K | -16K | -11K | -110K | -587K | -719K | -228K | 266K | 294K | 262K | 531K | 529K | 673K | 701K |
Operating Cash Flow | -9.9M | -9.28M | -8.83M | -8.96M | -7.85M | -7.75M | -8.53M | -9.18M | -10.47M | -11.74M | -11.55M | -11.97M | -11.19M | -10.37M | -9.35M | -8.14M | -7.66M | -3.33M |
Capital Expenditures | -29K | -24K | -25K | -13K | -41K | -47K | -33K | -39K | -16K | -68K | -84K | -127K | -136K | -80K | -69K | -33K | -26K | -28K |
Cash Acquisitions | n/a | n/a | n/a | -3.29K | -1.28K | n/a | n/a | 3.29K | 1.28K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -31.92M | -28.12M | -5.12M | -6.8M | -11.99M | -14.54M | -10.06M | -8.38M | -3.19M | -638K | n/a | n/a | n/a | n/a | n/a | -5M | -5M | -5M |
Sales Maturities Of Investments | 7.44M | 6.13M | 6.68M | 9.81M | 12.31M | 12.39M | 12.06M | 7.43M | 4.79M | 3.52M | n/a | 3M | 3M | 3M | 3.27M | 270K | 270K | 270K |
Other Investing Acitivies | n/a | n/a | n/a | 1.28K | 1.28K | n/a | 3K | -3.75M | -3.75M | -3.75M | -3.75M | n/a | n/a | n/a | n/a | -200K | -200K | -200K |
Investing Cash Flow | -24.5M | -22.01M | 1.54M | 3M | 287K | -2.19M | 1.97M | -4.74M | -2.17M | -937K | -3.84M | 2.87M | 2.86M | 2.92M | 3.2M | -4.96M | -4.95M | -4.96M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | 161.00 | 161.00 | 161.00 | 161.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 4.75M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3.38M | -3.38M | -3.38M | -3.38M | 3.38K | 3.38K | -3.37M |
Financial Cash Flow | 36.02M | 33.34M | 7.94M | 5.1M | 4.31M | 8.96M | 6.56M | 10.88M | 11.04M | 4.32M | 4.32M | -3.38M | -3.38M | -3.38M | -3.38M | 3.38K | 3.38K | -3.37M |
Net Cash Flow | 1.62M | 2.06M | 646K | -854K | -3.26M | -989K | -2K | -3.03M | -1.6M | -8.36M | -11.06M | -9.1M | -8.33M | -7.45M | -6.15M | -13.1M | -12.61M | -11.66M |
Free Cash Flow | -9.93M | -9.3M | -8.85M | -8.97M | -7.89M | -7.8M | -8.57M | -9.21M | -10.49M | -11.81M | -11.63M | -12.1M | -11.33M | -10.45M | -9.42M | -8.17M | -7.68M | -6.73M |